| Literature DB >> 35688011 |
Michael Scimeca1, Fatemeh Abdollahi2, Claudia Peñaloza3, Swathi Kiran2.
Abstract
Disparities in social determinants of health (SDOH) such as socioeconomic status and access to quality healthcare present serious barriers to enrollment in clinical rehabilitation programs for individuals who have experienced a stroke, especially for those who identify with a racial-ethnic minority group. Hispanic bilinguals with aphasia (HBWA) are one marginalized group who face even greater enrollment challenges since post-stroke language impairment and limited English proficiency make it difficult to advocate for one's needs and identify appropriate rehabilitation programs. Given the increasing representation of Hispanic individuals in the U.S. (projected to be 30% of the population in 2050), it is imperative that clinicians counter disparities in stroke care by facilitating access to clinical services for HBWA. However, the Hispanic population remains largely understudied in the stroke and aphasia literature, due in part to reduced opportunities to enroll in large-scale clinical research studies. In this paper we highlight how our team at Boston University has designed and implemented a variety of recruitment practices, assessment modifications, and treatment accommodations to circumvent the known barriers to participation in clinical research experienced by HBWA. Furthermore, we discuss the importance of cultural responsiveness and demonstrate how including principles of sensitivity and humility in clinical trial protocols improves participant enrollment and retention. Although clinical adjustments in this study were developed for use with HBWA, the effectiveness of the procedures suggests they may be useful blueprints for expanding access to research opportunities for various marginalized groups.Entities:
Keywords: Aphasia rehabilitation; Bilingual aphasia; Health disparities; Hispanic population; Social determinants of health; Teletherapy
Mesh:
Year: 2022 PMID: 35688011 PMCID: PMC9228944 DOI: 10.1016/j.jcomdis.2022.106231
Source DB: PubMed Journal: J Commun Disord ISSN: 0021-9924 Impact factor: 1.864